EyalHellerMD, BScab?TomasGarcia-SanchezPhDc?YonatanMoshkovitsBScabRaulRabinoviciPhDdDvoraGrynbergBScabAmitSegevMDabdSamuel J.AsirvathamMDeAntoniIvorraPhDcfEladMaorMD, PhDab
doi : 10.1016/j.jacep.2021.05.003
Volume 7, Issue 8, August 2021, Pages 959-964
This study compared monophasic 100-?s pulses with high-frequency electroporation (HF-EP) bursts using an in vivo animal model. Myocardial damage was evaluated by histologic analysis. Compared with 10 monophasic pulses, 20 bursts of HF-EP at 100 and 150 kHz were associated with less damage. However, when the number of HF-EP bursts was increased to 60, myocardial damage was comparable to that of the monophasic group. HF-EP protocols were associated with attenuated collateral muscle contractions. This study shows that HF-EP is feasible and effective and that pulse frequency has a significant effect on extent of ablation.
SuneetMittalMDaSusanOliverosCRATaJiaLiMScbThibautBarroyerMScbChristineHenryMScbChristopheGardellaPhDb
doi : 10.1016/j.jacep.2020.12.006
Volume 7, Issue 8, August 2021, Pages 965-975
The purpose of this study was to determine whether incorporation of a 2-part artificial intelligence (AI) filter can improve the positive predictive value (PPV) of implantable loop recorder (ILR)–detected atrial fibrillation (AF) episodes.
NirajVarmaMD, PhDaCharles J.LoveMDbJustinMichalskiMScAndrew E.EpsteinMDdTRUST Investigators
doi : 10.1016/j.jacep.2021.01.008
Volume 7, Issue 8, August 2021, Pages 976-987
The goal of this study was to test whether continuous automatic remote patient monitoring (RPM) linked to centralized analytics reduces nonactionable in-person patient evaluation (IPE) but maintains detection of at-risk patients and provides actionable notifications.
Fu SiongNgMRCP, PhDabcOnd?ejTomanMD, PhDdJanPetruMDePetrPeichlMD, PhDfRoger A.WinkleMDgVivek Y.ReddyMDhPetrNeuzilMD, PhDeR. HardwinMeadMDgNorman A.QureshiMRCP, PhDabZachary I.WhinnettMRCP, PhDabDavid W.BournPhD, MBAiM. BrentSheltonMS, MBAiJosefKautznerMD, PhDfArjun D.SharmaMDiMelezeHociniMDjMichelHaïssaguerreMDjNicholas S.PetersMDabIgor R.EfimovPhDk
doi : 10.1016/j.jacep.2020.12.014
Volume 7, Issue 8, August 2021, Pages 988-999
This first-in-human feasibility study was undertaken to translate the novel low-voltage MultiPulse Therapy (MPT) (Cardialen, Inc., Minneapolis, Minnesota), which was previously been shown to be effective in preclinical studies in terminating atrial fibrillation (AF), into clinical use.
Bharat K.KanthariaMD
doi : 10.1016/j.jacep.2021.01.012
Volume 7, Issue 8, August 2021, Pages 1000-1002
Ben B.ChungMDaJonathan S.GrinsteinMDaTeruhikoImamuraMD, PhDaEricKruseRDCSaAnn B.NguyenMDaNikhilNarangMDaLuise H.HolzhauserMDaDanielBurkhoffMD, PhDbRoberto M.LangMDaGabriel T.SayerMDaNir Y.UrielMD, MSca
doi : 10.1016/j.jacep.2021.01.016
Volume 7, Issue 8, August 2021, Pages 1003-1009
This study sought to evaluate the effects of right ventricular (RV) pacing versus biventricular (BiV) pacing on quality of life, functional status, and arrhythmias in LVAD patients.
Kenneth A.EllenbogenMDSantoshPadalaMD
doi : 10.1016/j.jacep.2021.06.014
Volume 7, Issue 8, August 2021, Pages 1010-1012
Monica Y.LoMDaPrashanthanSandersMBBS, PhDbPhillippSommerMDcJonathan M.KalmanMBBS, PhDdeUsman R.SiddiquiMDfSriSundaramMDgChristopherPiorkowskiMDhNicholasOlsonMDiSteven M.MadejBShDouglas N.GibsonMDi
doi : 10.1016/j.jacep.2021.01.019
Volume 7, Issue 8, August 2021, Pages 1013-1021
The objective of this clinical trial was to evaluate the safety and effectiveness of the TactiCath Contact Force Ablation Catheter, Sensor Enabled (TactiCath SE) (Abbott, Abbott Park, Illinois) for the treatment of drug-refractory, symptomatic paroxysmal atrial fibrillation (PAF).
DanielStevenMD, PhDJakobLükerMDArianSultanMD
doi : 10.1016/j.jacep.2021.04.007
Volume 7, Issue 8, August 2021, Pages 1022-1024
Francesca N.DellingMD, MPHaSidneyAungBAbEricVittinghoffPhDcShiktijDaveBAaLisa J.LimMSaJeffrey E.OlginMDaAndrewConnollyMDdEllenMoffattMDeZian H.TsengMD, MASa
doi : 10.1016/j.jacep.2021.01.007
Volume 7, Issue 8, August 2021, Pages 1025-1034
The goal of this study was to investigate the characteristics of mitral valve prolapse (MVP) in a post-mortem study of consecutive sudden cardiac deaths (SCDs) in subjects up to 90 years of age.
KyndaronReinierPhD, MPHSumeet S.ChughMD
doi : 10.1016/j.jacep.2021.03.009
Volume 7, Issue 8, August 2021, Pages 1035-1037
AntonioCretaMBBSab?RuiProvidênciaPhDac?ThomasGossiosPhDaPerry M.ElliottMDadChrisTurnerPhDeKonstantinosSavvatisMDadfOliver R.SegalMDa
doi : 10.1016/j.jacep.2021.01.017
Volume 7, Issue 8, August 2021, Pages 1038-1048
This study aimed to identify electrocardiographic (ECG) predictors of a prolonged His-ventricular (HV) interval in patients with type 1 myotonic dystrophy (DM1).
Susan P.EtheridgeMDMary C.NiuMD
doi : 10.1016/j.jacep.2021.07.002
Volume 7, Issue 8, August 2021, Pages 1049-1051
BalajiArvindDMaShyam S.KothariDMaRajnishJunejaDMaAnitaSaxenaDMaSivasubramanianRamakrishnanDMaSaurabh KumarGuptaDMaUjjwal K.ChowdhuryMChbVelayoudamDevagourouMChbSachinTalwarMChbMilind P.HoteMChbPalletiRajashekarMChbManoj KumarSahuMDbSarvesh PalSinghDMb
doi : 10.1016/j.jacep.2021.01.020
Volume 7, Issue 8, August 2021, Pages 1052-1060
This study sought to compare the efficacy of ivabradine and amiodarone in the management of postoperative junctional ectopic tachycardia (JET) after cardiac surgery in children.
Christopher M.JansonMD, CCDS, CEPS-PaColleen E.ClancyPhDb
doi : 10.1016/j.jacep.2021.03.015
Volume 7, Issue 8, August 2021, Pages 1061-1063
Ricardo A.SamsonMDAmber E.BealBSMargo E.HillCMA, CCTRowena L.FortinCMASean P.GallagherRN
doi : 10.1016/j.jacep.2021.04.008
Volume 7, Issue 8, August 2021, Pages 1064-1066
ThomasQuirinMScCorentinFéryMScHugoNicolasBScMorganMadecPhDLucHébrardPhDSvenKnechtPhDJorisPascalPhD
doi : 10.1016/j.jacep.2021.04.014
Volume 7, Issue 8, August 2021, Pages 1066-1068
AfsanAhmedBScMahmoodAhmadMBBS
doi : 10.1016/j.jacep.2021.03.020
Volume 7, Issue 8, August 2021, Pages 1068-1069
SuneetMittalMDChristineHenryMScChristopheGardellaPhD
doi : 10.1016/j.jacep.2021.03.022
Volume 7, Issue 8, August 2021, Pages 1069-1070
AsheshHalderDMJigneshGandhiMSSadashivChaudhariDNBHiravParikhMSHemantShindeMDYashLokhandwalaDM
doi : 10.1016/j.jacep.2021.06.022
Volume 7, Issue 8, August 2021, Pages 1070-1071
Filippo M.CautiMDPietroRossiMD, PhDMarcoPolselliMDJacopoVannucciMDDamianoMagr?MD, PhDFedericoVenutaMDMarcoAnileMD, PhDStefanoBianchiMD
doi : 10.1016/j.jacep.2021.07.001
Volume 7, Issue 8, August 2021, Pages 1071-1072
ZakiAkhtarMBBSChristosKontogiannisMDSumeetSharmaMDMark M.GallagherMD
doi : 10.1016/j.jacep.2021.05.017
Volume 7, Issue 8, August 2021, Pages 1072-1073
ChristianEllermannMDaGerritFrommeyerMDaStefanOrwatMDbHelmutBaumgartnerMDbLarsEckardtMDa
doi : 10.1016/j.jacep.2021.03.016
Volume 7, Issue 8, August 2021, Pages 1074-1075
PugazhendhiVijayaramanMD
doi : 10.1016/j.jacep.2021.04.005
Volume 7, Issue 8, August 2021, Pages 1076-1078
Do you want to add Medilib to your home screen?